GW Pharma's Epidiolex Offers Promise for Epilepsy Patients but Risk for Investors
Motley Fool Contributor Todd Campbell, who operates E.B. Capital Markets, LLC, a research firm providing action oriented ideas to professional investors, has been cautious on the prospects for GW Pharma (NASDAQ:...